Author:
Wang Jun,Wei Bing,Albarracin Constance T,Hu Jianhua,Abraham Susan C,Wu Yun
Abstract
Abstract
Background
Neuroendocrine carcinoma (NEC) of the breast is a rare type of carcinoma that has not been well studied or characterized. Of the limited number of studies reported in the literature, most are case reports. A few small retrospective series studies have been reported.
Methods
We reviewed data on 142 cases of mammary NEC recorded in the surveillance, epidemiology, and end results (SEER) database during 2003–2009 and evaluated disease incidence and patient age, sex, and race/ethnicity; clinicopathologic characteristics; and survival in comparison to invasive mammary carcinoma, not otherwise specified. We also performed univariate and multivariate analyses to identify prognostic factors in this disease.
Results
Review of the 142 SEER cases revealed that NEC is an aggressive variant of invasive mammary carcinoma. It generally occurred in older women (>60 years); present with larger tumor size (>20 mm), higher histologic grade, and higher clinical stage; and result in shorter overall survival and disease-specific survival than invasive mammary carcinoma, not otherwise specified (IMC-NOS). Overall survival and disease-specific survival were shorter in NEC at each stage than in IMC-NOS of the same stage. Furthermore, when all NEC and IMC-NOS cases were pooled together, neuroendocrine differentiation itself was an adverse prognostic factor independent of other known prognostic factors, including age, tumor size, nodal status, histologic grade, estrogen/progesterone receptor status, and therapy.
Conclusions
NEC is a rare but aggressive type of mammary carcinoma. Novel therapeutic approaches should be explored for this uniquely clinical entity.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference14 articles.
1. Cubilla AL, Woodruff JM: Primary carcinoid tumor of the breast: a report of 8 patients. Am J Surg Pathol. 1977, 1: 283-292. 10.1097/00000478-197712000-00001.
2. Fisher ER, Palekar AS: Solid and mucinous varieties of so-called mammary carcinoid tumors. Am J Clin Pathol. 1979, 72 (6): 909-916.
3. Azzopardi JG, Muretto P, Goddeeris P, Eusebi V, Lauweryns JM: ‘Carcinoid’ tumours of the breast: the morphological spectrum of argyrophil carcinomas. Histopathology. 1982, 6 (5): 549-569. 10.1111/j.1365-2559.1982.tb02750.x.
4. Papotti M, Macri L, Finzi G, Capella C, Eusebi V, Bussolati G: Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases. Semin Diagn Pathol. 1989, 6 (2): 174-188.
5. Miremadi A, Pinder SE, Lee AH, Bell JA, Paish EC, Wencyk P, Elston CW, Nicholson RI, Blamey RW, Robertson JF, Ellis IO: Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology. 2002, 40 (3): 215-222. 10.1046/j.1365-2559.2002.01336.x.
Cited by
115 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献